412 filings
Page 19 of 21
6-K
SBBP
Strongbridge Biopharma plc
9 Jun 16
Strongbridge Biopharma plc Announces Executive Promotion and Leadership Transition
12:00am
6-K
SBBP
Strongbridge Biopharma plc
3 Jun 16
Strongbridge Biopharma plc Announces Presentation at Jefferies 2016 Healthcare Conference
12:00am
6-K
SBBP
Strongbridge Biopharma plc
31 May 16
Strongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology
12:00am
SC 13D/A
Growth Equity Opportunities Fund III, LLC
18 May 16
Strongbridge Biopharma plc
12:00am
6-K
SBBP
Strongbridge Biopharma plc
17 May 16
Strongbridge Biopharma plc Reports First Quarter 2016 Financial Results
12:00am
6-K
SBBP
Strongbridge Biopharma plc
17 May 16
Current report (foreign)
12:00am
6-K
SBBP
Strongbridge Biopharma plc
14 Apr 16
Notice of Annual General Meeting to be held on 12 May 2016
12:00am
6-K
SBBP
Strongbridge Biopharma plc
6 Apr 16
Strongbridge Biopharma plc Announces Presentation at 15th Annual Needham Healthcare Conference
12:00am
6-K
SBBP
Strongbridge Biopharma plc
4 Apr 16
Current report (foreign)
12:00am
6-K
SBBP
Strongbridge Biopharma plc
24 Mar 16
Strongbridge Biopharma plc Reports Full-Year 2015 Financial Results
12:00am
20-F
2015 FY
SBBP
Strongbridge Biopharma plc
24 Mar 16
Annual report (foreign)
12:00am
6-K
SBBP
Strongbridge Biopharma plc
7 Mar 16
Strongbridge Biopharma plc Provides Update on Corporate Progress
12:00am
6-K
SBBP
Strongbridge Biopharma plc
25 Feb 16
Current report (foreign)
12:00am
6-K
SBBP
Strongbridge Biopharma plc
18 Feb 16
Strongbridge Biopharma Announces Annual General Meeting of Shareholders
12:00am
SC 13G
TVM V Life Science Ventures GMBH & Co KG
16 Feb 16
Strongbridge Biopharma plc
12:00am
SC 13G
Spetalen Eigil Stray
8 Feb 16
Strongbridge Biopharma plc
12:00am
SC 13G
SBBP
Strongbridge Biopharma plc
25 Jan 16
Strongbridge Biopharma plc
12:00am
SC 13G
Broadfin Capital, LLC
13 Jan 16
Strongbridge Biopharma plc
12:00am
6-K
SBBP
Strongbridge Biopharma plc
7 Dec 15
Strongbridge Biopharma Announces Issuance of U.S. Patent for Investigational COR-003 (levoketoconazole) in Treatment of Endogenous Cushing’s Syndrome
12:00am
CT ORDER
SBBP
Strongbridge Biopharma plc
1 Dec 15
Confidential treatment order
12:00am